First-in-Human Phase I Study of GSK2126458, an Oral Pan-Class I Phosphatidylinositol-3-Kinase Inhibitor, in Patients with Advanced Solid Tumor Malignancies (Q46689306)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | First-in-Human Phase I Study of GSK2126458, an Oral Pan-Class I Phosphatidylinositol-3-Kinase Inhibitor, in Patients with Advanced Solid Tumor Malignancies |
scientific article |
Statements
1 reference
First-in-Human Phase I Study of GSK2126458, an Oral Pan-Class I Phosphatidylinositol-3-Kinase Inhibitor, in Patients with Advanced Solid Tumor Malignancies (English)
1 reference
Razelle Kurzrock
1 reference
E Claire Dees
1 reference
Jan H M Schellens
1 reference
Pamela Munster
1 reference
Rahul Aggarwal
1 reference
David Hong
1 reference
Ruud van der Noll
1 reference
Jennifer Specht
1 reference
Petronella O Witteveen
1 reference
Theresa L Werner
1 reference
Emily Bergsland
1 reference
Neeraj Agarwal
1 reference
Joseph F Kleha
1 reference
Michael Durante
1 reference
Laurel Adams
1 reference
Deborah A Smith
1 reference
Thomas A Lampkin
1 reference
Shannon R Morris
1 reference
24 November 2015
1 reference
22
1 reference
8
1 reference
1932-1939
1 reference